Cite

HARVARD Citation

    Kingsbury, D. et al. (n.d.). A152: Safety and Effectiveness of Adalimumab in Children With Polyarticular Juvenile Idiopathic Arthritis Aged 2 to 4 Years. Arthritis & rheumatology. 66 (11), pp. S196-S197. [Online]. 
  
Back to record